NASDAQ NMS - GLOBAL MARKET · BEAT
-4.18% · -$0.0200 · Vol 1.5M
Market closed · last close 4:00 PM ET · price as of 19:58:15 ET
Heartbeam Inc

Heartbeam Inc

Health Care
$0.4683
Card
Relationship Map

Follow $BEAT

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $BEAT by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
BEAT
Heartbeam Inc
Fri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
Upper range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 5 of 6 factors measured · Fri Oct 9 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BEAT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BEAT catalysts
About Heartbeam Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2021
Employees
16
Country
US

HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.4900
Day high
$0.5099
Day low
$0.4710
Previous close
$0.4887
52W high
$3.44
-86.39% from high
52W low
$0.3598
4% of range
Market cap
$27.5M
EPS
$-0.5112
Beta
2.40
Shares out
56.3M
Volume
1.5M
0.10× rel vol
Avg volume
14.8M
VWAP
$0.4876
Price history computed in-house
1W
+7.75%
1M
+14.10%
3M
-22.60%
1Y
-71.62%
YTD
-80.49%
SMA 50 $0.4669 · above
SMA 200 $1.02 · below
52W position 4%

BEAT overview

Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file
Loading financial statements
Loading BEAT Form 4 filings
Public disclosures

Congress activity in BEAT

No receipt-qualified filings found.

Federal contracts

BEAT contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BEAT in this window.
Lobbying spend

BEAT lobbying filings, year to date.

Registered lobbying filings matched to Heartbeam Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BEAT in this window.
Loading news for BEAT
Analyst ratings
Sovereign unlock shows live analyst consensus for BEAT.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.